SCHEMBL7186922

SCHEMBL7186922

O=[C]/C=C/c1c[nH]cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1160111 1.00
SCHEMBL9547410 0.79
SCHEMBL9547405 0.79
Acetic Acid SCHEMBL9547147 0.73 HDAC3 (0.34)
Acetic Acid SCHEMBL9547145 0.73 HDAC3 (0.34)
SCHEMBL2632247 0.72 MAPT (0.41)
SCHEMBL6675935 0.71
SCHEMBL13654262 0.71
Cis-Urocanic Acid SCHEMBL15417 0.69 KDM4E (0.43)
Cis-Urocanic Acid SCHEMBL19031717 0.69 KDM4E (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6566355-B1 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens HOFFMANN-LA ROCHE INC. 2003-05-20 US disclosed
WO-1998008492-A1 TRANSDERMAL DELIVERY OF PEPTIDES NOVO NORDISK A/S (DK) 1998-03-05 WO disclosed
US-5712268-A Compositions of tricyclic β-lactams and uses thereof HOFFMANN-LA ROCHE INC. (US) 1998-01-27 US disclosed
US-5698577-A ANTIBIOTICS HOFFMANN-LA ROCHE INC. (US) 1997-12-16 US disclosed
EP-0508234-B1 Beta-lactames HOFFMANN LA ROCHE (CH) 1996-07-24 EP disclosed
US-5510343-A BETA-LACTAMASE INHIBITOR HOFFMANN-LA ROCHE INC. (US) 1996-04-23 US disclosed
EP-0508234-A2 Beta-lactames F. HOFFMANN-LA ROCHE AG (CH) 1992-10-14 EP disclosed